Navigation Links
Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need
Date:7/10/2014

dicated for long-term female contraception, the product has also received approval by regulatory authorities in the European Union and several countries around the world.

Information gathered in these countries will enable health program planners to make informed decisions regarding whether and how to include Sayana® Press among their family planning offerings.

Family planning could prevent up to one-third of all maternal deaths by allowing women to delay motherhood, space births, avoid unintended pregnancies and unsafe abortions, and stop childbearing when they reach their desired family size.

“This initiative is a major innovation in family planning service delivery,” said PATH President and CEO Steve Davis. “By making injectable contraceptives available at the community level, it offers more women control over the timing and spacing of their children, and a better chance at a healthy life.”

Injectable contraception is a popular family planning method among women in developing countries. In some places, women must return to a clinic every three months for a new injection, limiting access in remote and other hard-to-reach areas. The contraceptive’s delivery system allows injections to be provided by health workers to women at home or in other convenient settings.

The BD Uniject prefilled autodisable injection system was originally developed by PATH, with support from USAID, and has been licensed to Becton, Dickinson and Company (BD). The system allows the contraceptive to be delivered via subcutaneous injection, in the fat layer between the skin and muscle. It also eliminates the need to prepare a needle and syringe.

“At the right price, Sayana® Press will expand contraceptive choice and increase access to family planning, especially in rural and hard-to-reach communities in low-resource settings,” said Ellen Starbird, Director of the Office of Population and Reproductive Health at USAID.

This in
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019
2. European Injectable Drug Delivery Report 2013: Market Forecasts to 2017
3. Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017
4. North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017
5. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
6. North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
7. Mylan to Acquire Agila to Create Leading Global Injectables Platform
8. Using 3-D printing and injectable molds, bioengineered ears look and act like the real thing
9. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
10. Contraceptives Market is Expected to Reach USD 23.3 Billion Globally in 2018: Transparency Market Research
11. HerKare Launched To Exclusively Treat Hormone Imbalance In Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... MISSISSAUGA, ON , April 23, 2015 /CNW/ ... major sustainable packaging award from North ... Packaging,s Brandcheck Competitor Comparison won Silver in the ... Awards. The Brandcheck "Competitor Comparison" is ... set of North American and Global peers. This ...
(Date:4/23/2015)... California (PRWEB) April 23, 2015 ... diagnostics refer to a series of genetic tests ... cystic fibrosis, Lou Gehrig's disease, Huntington's disease, and ... examining the gene composition and interaction in diseased ... disease as well as the response to treatment, ...
(Date:4/23/2015)... (PRWEB) April 23, 2015 ... in Personalized Medicine, is excited to announce the ... profile . This profile assesses 62 genetic variations ... dosing information for commonly prescribed non-opioid pain medications, ... name Neurontin), alprazolam (brand name Xanax) and acetaminophen ...
(Date:4/23/2015)... 2015 Delpor, Inc. (Delpor), a biotechnology ... United States Patent and Trademark Office has issued 2 ... technology. US Pat. No. 8,986,727 was issued on ... delivery device for the sustained release of therapeutic ... the sustained (zero-order) release of large and small molecules ...
Breaking Biology Technology:Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 2Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 3Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 2Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 3Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3
... 2011 Cumberland Pharmaceuticals Inc. (NASDAQ: ... care and gastroenterology markets, today announced third quarter 2011 financial ... months ended September 30, 2011, net revenue was $13.1 million, ... growth in net revenue was driven by an increase in ...
... 2011 Cempra Pharmaceuticals will be presenting data ... (MRSA) strains isolated from cystic fibrosis (CF) ... human lung epithelial in vitro model ... Conference in Anaheim, California.  Both studies will be ...
... 3, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Product Development at BioMarin, will present a company update at ... 10, 2011 at 3:30 p.m. MST.   Interested ... call via the investor section of the BioMarin website, ...
Cached Biology Technology:Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 8Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 9Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 10Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 11Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 12Taksta™ (fusidic acid) Demonstrates Activity Against MRSA Isolated From Cystic Fibrosis Patients 2Taksta™ (fusidic acid) Demonstrates Activity Against MRSA Isolated From Cystic Fibrosis Patients 3BioMarin to Present at the Credit Suisse Healthcare Conference 2
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
(Date:3/26/2015)... March 26, 2015 The Granite ... recreation and athletic club, today announced it has implemented ... freedom of movement for members and staff, while restricting ... comprehensive process, we selected FST,s IMID Access system because ... for our members and staff, in addition to unparalleled ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... study performed at Children,s Hospital Los Angeles found no evidence ... nerve hypoplasia (ONH). Their results are reported in the ... ( AAPOS ). ONH, an underdevelopment of optic ... an isolated abnormality or as part of a group of ...
... study published online in the journal PLOS Pathogens , ... single amino acid they could change the sugar to which ... cells. The BK polyomavirus lost the ability to bind its ... its cousin SV40 polyomavirus, which is active in monkeys. ...
... Research Careers) Program has announced the travel award recipients ... VA from October 31-November 3, 2013. These awards are ... postdoctorates and scientists into the mainstream of the basic ... postdocs and new assistant professors. This year MARC conferred ...
Cached Biology News:No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 3Single mutation gives virus new target 2MARC travel awards announced for 2013 Institute on Teaching and Mentoring 2
Imject Freund's Incomplete Adjuvant (FIA)...
With sodium bicarbonate. Sterile, Cell culture tested...
A substrate for all AChE-based EIA kits....
... gel stain was developed specifically for reduced mutagenicity ... staining DNA in agarose or acrylamide gels. SYBR ... ethidium bromide but SYBR Safe stain's detection sensitivity ... Safe stain comes as a premixed solution that ...
Biology Products: